Abivax SA Sponsored ADR (ABVX)
(Delayed Data from NSDQ)
$13.86 USD
-0.04 (-0.29%)
Updated May 24, 2024 04:00 PM ET
After-Market: $13.79 -0.07 (-0.51%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ABVX 13.86 -0.04(-0.29%)
Will ABVX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ABVX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ABVX
Abivax initiated with bullish view at BTIG, here's why
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Abivax SA Sponsored ADR (ABVX)
Abivax SA Announces Upcoming General Meeting
Apple upgraded, Tesla downgraded: Wall Street's top analyst calls
Abivax initiated with a Buy at Guggenheim on obefazimod's potential